Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · Oklahoma
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Oklahoma City (700,000 residents, 1,480,000 metro). Oklahoma expanded Medicaid in 2021 via SoonerCare; OU Health is the major academic anchor.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Oklahoma City →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Oklahoma City →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Oklahoma City →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Oklahoma City →
Oklahoma City is a south-region city with a population of 700,000 (1,480,000 in the broader metropolitan area). Oklahoma expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include OU Health, Saint Francis Health System.
Oklahoma's Medicaid program is SoonerCare. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.